News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Newborn Screening and Early Treatment for Rare Genetic Disorder, LA BioMed Reveals


12/29/2010 7:46:27 AM

(Ivanhoe Newswire) – Researchers believe that newborn screening and early treatment for a rare genetic disorder, mucopolysaccharidosis type I (MPS I), is needed so that enzyme replacement therapy can begin at birth and eliminate all the symptoms associated with MPS I.

Read at Ivanhoe

comments powered by Disqus
Ivanhoe
LA BioMed
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES